On January 22, 2019, the Supreme Court issued a decision in
Helsinn Healthcare S.A. et al. v. Teva Pharmaceuticals USA,
Inc., No. 17-1229. The Supreme Court unanimously held that the
America Invents Act (AIA) on-sale bar, like the pre-AIA on-sale
bar, extends to "secret sales."
Background
Under pre-AIA law, a sale or offer for sale of an
invention—including an inventor's "secret"
sales to a third party that is required to keep the invention
confidential—could act as a bar to patentability. The AIA
retained the pre-AIA "on sale" terminology but added the
catch-all phrase "or otherwise available to the public."
The US Patent and Trademark Office (USPTO) subsequently issued
guidelines explaining that the AIA on-sale bar does not cover
"secret sales" and explained that activities are
"secret" if they are among individuals having an
obligation of confidentiality to the inventor. The district court
that decided the Helsinn case initially applied the